Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 138
- Locations
- 1
- Primary Endpoint
- Muscle wasting in COPD patient
Study Overview
Brief Summary
Peripheral muscle mass and strength are relevant indicators of COPD survival. Current guidelines recommend to assess muscle strength only in muscle wasted patients. However, a recent study reported quadriceps weakness without muscle wasting (Menon, M et al. Resp. Res.2012, 13:119). Thus, these guidelines raise the risk to miss out some weak patients. In clinical settings, fat-free-mass index (FFMI) is indicated as a simple index to assess muscle wasting. We aimed at determining the prevalence of patients entering in pulmonary rehabilitation (PR) a priori not eligible for muscle strength evaluation given the lack of muscle wasting clinical signs.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients who have got FFMI (bioimpedance)
- •Patients who have done quadriceps muscle strenght evaluation
Exclusion Criteria
- •Patients without FFMI
- •Patients without quadriceps muscle strenght
Outcomes
Primary Outcomes
Muscle wasting in COPD patient
Time Frame: baseline
Secondary Outcomes
- Muscle weakness in COPD patient(baseline)
